Table 1.
Diagnostic yield from 339 epilepsy patients screened on the Epilepsy and Seizure disorders panel.
Pathogenic and Likely Pathogenic variants | |||||
Case No. | Gene | Nucleotide | Protein | Classification | Phenotype (if provided) |
1 | ALDH7A1 | c.1093+1G>A, c.1279G>C | p.Glu427Gln | Pathogenic | Seizures, epileptic encephalopathy, macrocephaly, hypotonia, muscle weakness, and developmental delay |
2 | ARX | c.30C>A | p.Cys10Ter | Pathogenic | Infantile spasms, dysphagia, and poor weight gain |
3 | CDKL5 | c.1891_1916delATAGGGCAAGGGATGGCAGCTAGAGC | p.Ile631Glnfs*43 | Pathogenic | Unspecified Epilepsy |
4 | CDKL5 | c.1152C>G | p.Tyr384Ter | Pathogenic | Epileptic encephalopathy, myotonic and tonic-clonic seizures, and a course gyral pattern on brain imaging |
5 | CDKL5 | c.1553delC | p.Pro518Hisfs*5 | Pathogenic | Seizures and spasticity |
6 | CDKL5 | c.212delA | p.Asn71Thrfs*5 | Pathogenic | Infantile/epileptic spasms and hypotonia |
7 | CDKL5 | c.1108_1109dupAA | p.Asn370Lysfs*124 | Pathogenic | N/A |
8 | FOXG1 | c.648_655delTTACTACC | p.Tyr217Argfs*235 | Pathogenic | Unspecified Epilepsy |
9 | GABRA1 | c.335G>A | p.Arg112Gln | Likely Pathogenic | N/A |
10 | GABRA1 | c.640C>A | p.Arg214Ser | Likely pathogenic | Generalized convulsive epilepsy with intractable epilepsy |
11 | GRIN2A | c.2890delC | p.Gln964Lysfs*37 | Pathogenic | Generalized seizures and speech disturbance |
12 | GRIN2A | c.3813G>A | p.Trp1271Ter | Pathogenic | N/A |
13 | KCNA1 | c.1222G>A | p.Val408Met | Likely Pathogenic | Seizures, developmental delay, and multiple joint contractures |
14 | KCNQ2 | c.793G>A | p.Ala265Thr | Likely pathogenic | Neonatal seizure disorder |
15 | KCNQ2 | c.637C>T | p.Arg213Trp | Pathogenic | Neonatal seizure disorder |
16 | KCNQ2 | c.640C>T | p.Arg214Trp | Likely pathogenic | Autism, seizures, hydrocephaly, a brother with autism and epilepsy, and a father with a history of epilepsy in childhood |
17 | KCNQ2 | c.1118+2T>C | Pathogenic | Infantile/epileptic spasms | |
18 | KCNQ2 | c.701C>T | p.Thr234Ile | Likely pathogenic | Seizures and developmental delay |
19 | KCNQ2 | c.821C>T | p.Thr274Met | Likely pathogenic | N/A |
20 | KCNQ2 | c.841G>A | p.Gly281Arg | Likely pathogenic | N/A |
21 | KCNQ2 | c.1088A>G | p.Tyr363Cys | Likely pathogenic | Neonatal seizure disorder and epileptic encephalopathy |
22 | KCNT1 | c.2849G>A | p.Arg950Gln | Likely Pathogenic | N/A |
23 | MECP2 | c.880C>T | p.Arg294Ter | Pathogenic | Delayed milestones and intractable epilepsy |
24 | PCDH19 | c.814C>T | p.Gln272Ter | Pathogenic | Seizure disorder |
25 | PCDH19 | c.1091dupC | p.Tyr366Leufs*10 | Pathogenic | Intellectual disability, autism, and seizures |
26 | PCDH19 | c.1265_1266delCA | p.Thr422Asnfs*23 | Pathogenic | N/A |
27 | SCN1A | c.2584C>T | p.Arg862Ter | Pathogenic | Psychomotor epilepsy, intellectual disability, phenotype consistent with Dravet syndrome |
28 | SCN1A | c.4907G>A | p.Arg1636Gln | Likely pathogenic | Epileptic encephalopathy, myoclonic seizures, dystonia, and spasticity |
29 | SCN1A | c.602+1G>A | Pathogenic | Seizures and developmental delay | |
30 | SCN1A | c.269T>C | p.Phe90Ser | Likely pathogenic | Prolonged seizures, possible myoclonus, and a clinical suspicion for Dravet syndrome |
31 | SCN1A | c.1264G>A | p.Val422Met | Likely pathogenic | Infantile spasms, focal seizures, hypotonia, bilateral polydactyly, lack of coordination, and grand mal status |
32 | SCN1A | c.1259C>A | p.Ala420Asp | Likely pathogenic | N/A |
33 | SCN1A | c.302G>A | p.Arg101Gln | Pathogenic | N/A |
34 | SCN1A | c.5389G>C | p.Ala1797Pro | Likely Pathogenic | Tonic-clonic and focal seizures |
35 | SCN1A | c.5348C>T | p.Ala1783Val | Pathogenic | N/A |
36 | SCN1A | c.4812delG | p.Trp1604Ter | Pathogenic | N/A |
37 | SCN1A | c.5563C>T | p.Pro1855Ser | Likely Pathogenic | N/A |
38 | SCN1A | c.1076A>G | p.Asn359Ser | Likely Pathogenic | N/A |
39 | SCN1B | c.347delC | p.Ser116Trpfs*31 | Pathogenic | Hypotonia and seizures |
40 | SCN1B | c.653delG | p.Ser218Thrfs*21 | Likely Pathogenic | Developmental delay, seizures with an abnormal EEG, and high myopia |
41 | SCN1B | c.363C>G | pCys121Trp | Pathogenic | N/A |
42 | SCN1B | c.363C>G | pCys121Trp | Pathogenic | N/A |
43 | SCN2A | c.5387_5390dup AGAT | p.Met1797Ilefs*5 | Pathogenic | Seizures and intellectual disability |
44 | SCN2A | c.5645G>A | p.Arg1882Gln | Likely pathogenic | Lack of normal physiological development, autism spectrum disorder, and intractable epilepsy |
45 | SCN2A | c.2558G>A | p.Arg853Gln | Pathogenic | Failure to thrive, developmental delay, speech delay, autism, seizures, dystonia, microcephaly, and gastroesophageal reflux disease |
46 | SCN2A | c.1178C>A | p.Thr393Lys | Likely Pathogenic | Seizures and developmental regression |
47 | SCN2A | c.2713A>G | p.Lys905Glu | Likely Pathogenic | Epileptic encephalopathy |
48 | SCN8A | c.3985A>G | p.Asn1329Asp | Likely pathogenic | Intractable epilepsy |
49 | SCN8A | c.2287A>G | p.Ile763Val | Likely Pathogenic | Seizures and developmental delay |
50 | SLC2A1 | c.997C>T | p.Arg333Trp | Pathogenic | Febrile seizures, ataxia, hypotonia, hypermobility, and a family history of seizures. |
51 | SLC2A1 | c.1006C>G | p.Leu336Val | Likely Pathogenic | N/A |
52 | SLC9A6 | c.508–1G>A | Pathogenic | N/A | |
53 | STXBP1 | c.1029+1G>T | Pathogenic | Seizures, developmental delay, and cognitive impairment. | |
54 | STXBP1 | c.364C>T | p.Arg122Ter | Pathogenic | Infantile/epileptic spasms and tonic seizures |
55 | STXBP1 | c.548T>C | p.Leu183Pro | Likely Pathogenic | N/A |
56 | STXBP1 | c.704G>A | p.Arg235Gln | Likely Pathogenic | Generalized, absence, and tonic-clonic seizures, infantile spasms, hypotonia, developmental delay, and cerebral palsy |
57 | SYN1 | c.377G>A | p.Trp126Ter | Pathogenic | N/A |
58 | TPP1* | c.509–1G>C | Pathogenic | N/A | |
59 | TPP1 | c.509–1G>C, c.1016G>A | p.Arg339Gln | Pathogenic | Seizures and speech delay |
60 | TSC2 | c.4415delG | p.Gly1472Alafs*4 | Pathogenic | Seizure disorder and intellectual disability |
61 | TSC2 | c.3598C>T | p.Arg1200Trp | Pathogenic | Infantile spasms and global developmental delay |
62 | ZEB2 | c.1876G>T | p.Gly626Ter | Pathogenic | Developmental delay and psychomotor epilepsy |
Potentially Causative Variants | |||||
Case No. | Gene | Nucleotide | Protein | Classification | Phenotype (if provided) |
63 | CACNA1A | c.5017C>T | p.Arg1673Cys | Unknown | Generalized convulsive epilepsy and hemiplegia |
64 | CACNA1A | c.4177G>A | p.Val1393Met | Unknown | Global developmental delay, seizures, and tremor |
65 | CACNA1A | c.4177G>A | p.Val1393Met | Unknown | N/A |
66 | CDKL5 | c.541G>A | p.Glu181Lys | Unknown | N/A |
67 | HCN1 | c.990G>C | p.Trp330Cys | Unknown | Epileptic encephalopathy, abnormal EEG, and other clinical features suggestive of Ohtahara syndrome |
68 | FLNA | c.4237G>A | p.Glu1413Lys | Unknown | Hypotonia, epilepsy, and abnormal MRI |
69 | KCNQ2 | c.1627G>A | p.Val543Met | Inherited | Developmental delay, seizures, a ventricular septal defect, unilateral cryptorchidism, and macrocephaly |
70 | KCNQ2 | c.1627G>A | p.Val543Met | Unknown | N/A |
71 | KCTD7 | c.190A>G, c.793G>A | p.Thr64Ala, p.Gly265Arg | Inherited from both parents | Status epilepticus, generalized, tonic-clonic, and myoclonic seizures |
72 | MEF2C | c.121T>C | p.Cys41Arg | Unknown | Generalized and myoclonic seizures, intellectual disability, hypotonia, spasticity, and muscle weakness |
73 | NRXN1 | c.3619C>T | p.Arg1207Ter | Unknown | Autism, epilepsy, and developmental delay |
74 | PNKP* | c.1324G>A | p.Gly442Ser | Unknown | N/A |
75 | RELN | c.1817C>T, c.2201T>A | p.Thr606Ile, p.Val734Asp | Inherited from both parents | Cerebral palsy, abnormal EEG, developmental delay, and lack of coordination |
76 | SCN1A | c.638C>G | p.Ser213Trp | Unknown | Febrile and afebrile seizures and developmental delay |
77 | SCN1A | c.1703G>A | p.Arg568Gln | Unknown | Seizures |
78 | SCN1A | c.2923G>C | p.Val975Leu | Unknown | Seizures and developmental delay |
79 | SCN2A | c.4156T>G | p.Cys1386Gly | Unknown | Seizures, speech and developmental regression |
80 | SCN8A | c.491C>T | p.Thr164Met | Inherited from affected mother | Focal seizures, developmental delay, failure to thrive, and a maternal family history of seizures |
81 | SCN8A | c.605T>A | p.Ile202Asn | Unknown | Seizures, developmental delay, dysmorphic features, pica, paroxysmal behavior with nonspecific encephalopathy on EEG, and a brother who also has seizures |
82 | SCN8A | c.1241A>T | p.Tyr414Phe | Unknown | N/A |
83 | TPP1*‡ | c.523C>T | p.Arg175Cys | Unknown | Infantile spasms, learning disability, developmental delay, seizures, and hypotonia |
N/A, phenotype was not available
Indicates a homozygous variant
This individual also had a novel homozygous missense variant in SLC25A22